- Definition: Home sleep testing (HST) is a diagnostic approach for obstructive sleep apnea that uses a portable device worn by the patient during sleep in their own home, typically over one or two nights. It is designed to detect respiratory events and oxygen desaturation without the need for a laboratory setting.
- Purpose: HST aims to identify patients with moderate to severe OSA who are candidates for treatment such as positive airway pressure therapy. It is not intended for diagnosing other sleep disorders like narcolepsy or periodic limb movement disorder.
- Contrast with in-lab PSG: In-laboratory polysomnography (PSG) measures a full range of physiological signals including EEG, EOG, and EMG, while HST typically captures only respiratory parameters, oximetry, and heart rate. PSG is the reference standard, but HST offers comparable accuracy for high-probability OSA patients.
- Device categories: The American Academy of Sleep Medicine classifies HST devices as Type III (minimum of 4 channels, including airflow, respiratory effort, and oximetry) and Type IV (1-2 channels, usually oximetry alone). Type III devices are most common in clinical practice.
- Clinical utility: HST is appropriate for patients with a high pretest probability of moderate to severe OSA, such as those with loud snoring, witnessed apneas, and daytime sleepiness. It reduces wait times, costs, and patient burden compared to in-lab studies.
- Limitations: HST may underestimate apnea severity because it lacks EEG to distinguish sleep from wake, and it cannot detect central sleep apnea reliably. It also requires adequate patient training to ensure proper sensor placement and device operation.
- Role in sleep medicine: HST is a key tool for expanding access to OSA diagnosis, particularly in rural or underserved areas. It is frequently used in integrated care models where primary care providers initiate testing before specialist review.
- Regulatory status: HST devices are regulated by the FDA as Class II medical devices. Many require a prescription and must be applied under the supervision of a sleep specialist or qualified healthcare professional.
- Patient preparation: Before sending the device home, the technician must provide clear instructions on sensor placement, device charging, and what to do if sensors loosen overnight. Written guides and video tutorials improve adherence. Patients should avoid naps and caffeine on test day and maintain their usual sleep schedule for accurate results.
- Data quality assessment: Upon device return, the coordinator checks for a minimum of four hours of recorded data, adequate oximetry signal quality, and proper sensor connection. Studies with less than four hours or poor signal are considered technically inadequate and may require a repeat test to ensure diagnostic accuracy.
- Contraindications: HST is not recommended for patients with suspected central sleep apnea, significant cardiopulmonary comorbidities, severe insomnia, or those who require supplemental oxygen. Individuals with neuromuscular disorders or opioid use may also be excluded because the test cannot reliably classify respiratory events.
- Scoring and interpretation: HST data are scored using the same apnea hypopnea index thresholds as PSG, but the total recording time is used as the denominator rather than total sleep time. This can lead to a lower AHI in patients with fragmented sleep. Scoring is performed by trained technicians and then reviewed by a board certified sleep physician.
- Follow up protocol: After the physician interprets the HST report, the patient is contacted to discuss results and treatment options. If the study is negative but clinical suspicion remains high, a repeat home test or in lab PSG may be ordered. A positive result with moderate to severe AHI typically leads to a PAP therapy prescription.
Role: Sleep Technician or Coordinator in a Home Sleep Testing Program
- Educating patients on device setup and usage
- Reviewing device return and data completeness
- Troubleshooting common equipment issues
- Documenting patient questions and concerns
- Interpreting HST data independently
- Diagnosing OSA without physician review
- Modifying device settings without protocol
- Providing treatment recommendations
Regulation: HST devices are classified as Class II medical devices under FDA regulation 21 CFR 874.1430. They require a prescription and must be used in accordance with the device labeling. Facilities should maintain documentation of device training and maintenance.
Source: FDA Guidance Document. Home Sleep Apnea Testing Systems. 2018.
- Home sleep testing is a portable diagnostic method for moderate to severe obstructive sleep apnea.
- It measures respiratory parameters and oximetry but not sleep stages.
- Type III devices are preferred for clinical use.
- HST is appropriate for high-probability patients and requires proper patient education.
- Limitations include potential underestimation of severity and inability to detect central apnea.